Jos Kitzen
Impact in
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer survivorship and care
- Cancer Treatment and Pharmacology
-
- Natural Compounds in Disease Treatment
Papers in
- Oncology 18
- HER2/EGFR in Cancer Research 9
- Cancer Treatment and Pharmacology 5
- Peptidase Inhibition and Analysis 5
- Cancer survivorship and care 4
- Colorectal Cancer Treatments and Studies 2
-
- Chemotherapy-induced cardiotoxicity and mitigation 5
- Co-authors
- Jaap Verweij (11 shared papers)Maja J.A. de Jonge (3 shared papers)Jos Verbeek (3 shared papers)Walter J. Loos (4 shared papers)Guus Fons (3 shared papers)Peter W. Plaisier (3 shared papers)Monique M.E.M. Bos (3 shared papers)Monique H. W. Frings‐Dresen (3 shared papers)
- Journals
- European Journal of Cancer (4 papers)The Oncologist (2 papers)Journal of Occupational Rehabilitation (2 papers)Cancer Biology & Therapy (2 papers)Breast Cancer Research and Treatment (2 papers)
- Partner nations
- NetherlandsFinlandUnited Kingdom
In The Last Decade
Jos Kitzen
24 papers receiving 609 citations
Peers
Comparison fields: 5 of 79
- Oncology 314
- Complementary and alternative medicine 64
- Pharmacology 79
- Cell Biology 65
- Geriatrics and Gerontology 14
Countries citing papers authored by Jos Kitzen
This map shows the geographic impact of Jos Kitzen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jos Kitzen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jos Kitzen more than expected).
Fields of papers citing papers by Jos Kitzen
This network shows the impact of papers produced by Jos Kitzen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jos Kitzen. The network helps show where Jos Kitzen may publish in the future.
Co-authors
The 25 scholars most cited alongside Jos Kitzen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 82 | |
| 2 | 2009 | 77 | |
| 3 | 2013 | 67 | |
| 4 | 2007 | 65 | |
| 5 | 2007 | 52 | |
| 6 | 2012 | 38 | |
| 7 | 2009 | 33 | |
| 8 | 2020 | 30 | |
| 9 | 2007 | 22 | |
| 10 | 2017 | 22 | |
| 11 | 2021 | 20 | |
| 12 | 2011 | 18 | |
| 13 | 2019 | 15 | |
| 14 | 2019 | 15 | |
| 15 | 2006 | 15 | |
| 16 | 2022 | 11 | |
| 17 | 2019 | 8 | |
| 18 | 2005 | 7 | |
| 19 | 2009 | 7 | |
| 20 | 2006 | 7 |
About Jos Kitzen
Jos Kitzen is a scholar working on Oncology, Cardiology and Cardiovascular Medicine, Molecular Biology, Pediatrics, Perinatology and Child Health and Radiology, Nuclear Medicine and Imaging, having authored 25 papers that have together received 625 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (9 papers), Cancer Treatment and Pharmacology (5 papers), Chemotherapy-induced cardiotoxicity and mitigation (5 papers), Peptidase Inhibition and Analysis (5 papers), Cancer survivorship and care (4 papers), Pharmacological Effects and Toxicity Studies (2 papers), Colorectal Cancer Treatments and Studies (2 papers) and Pharmacogenetics and Drug Metabolism (2 papers). The work is most often cited by research in Oncology (314 citations), Complementary and alternative medicine (64 citations), Pharmacology (79 citations), Cell Biology (65 citations) and Geriatrics and Gerontology (14 citations). Jos Kitzen has collaborated with scholars based in Netherlands, Finland and United Kingdom. Frequent co-authors include Jaap Verweij, Maja J.A. de Jonge, Jos Verbeek, Walter J. Loos, Guus Fons, Peter W. Plaisier, Monique M.E.M. Bos, Monique H. W. Frings‐Dresen, Angela G. E. M. de Boer and Sietske J. Tamminga. Their work appears in journals such as European Journal of Cancer, The Oncologist, Journal of Occupational Rehabilitation, Cancer Biology & Therapy and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.